CannabisNewsBreaks Archive - Page 398 of 420

WednesdayOct 18, 2017 11:29 am

CannabisNewsBreaks – Pressure BioSciences, Inc. (PBIO) Enters Collaboration Agreement with Phasex Corporation

Pressure BioSciences, Inc. (“PBI”) (OTCQB: PBIO), a leader in the development and sale of innovative solutions for the worldwide life sciences industry, this morning announced a collaboration with Phasex Corporation, one of the world’s most experienced supercritical fluid (“SCF”)-based toll processors. The goal of the collaboration is to combine PBI’s recently patented Ultra Shear Technology with Phasex’s SCF-based processing methods to enable the development of stable, water-soluble nanoemulsions of nutraceuticals, including CBD-enriched plant oil. “Rapidly expanding markets for non-psychoactive extracts of cannabis plant material, for instance, is an example of a potentially high demand application for our combined, synergistic technologies,” Richard…

WednesdayOct 18, 2017 10:43 am

CannabisNewsBreaks – EVIO, Inc. (EVIO) Announces Strong Start to Fiscal 2018

EVIO, Inc. (OTCQB: EVIO), a leading provider of cannabis analytical testing services, this morning announced that its EVIO Labs division has already exceeded last October’s testing revenues through the first half of October 2017, with sales surpassing $250,000. “Our national sales team continues to expand EVIO's service offerings,” William Waldrop, CEO of EVIO, stated in the news release. “After an impressive 2017, in which we exceeded our own internal projections, we are starting the 2018 fiscal year on the right track. We are eagerly waiting for the upcoming accreditation of our new pesticide equipment. As mentioned in our 8K, the…

WednesdayOct 18, 2017 9:33 am

CannabisNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Approaching Commercialization of IGC-AD1 in Early 2018

India Globalization Capital, Inc. (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning provided compelling in vitro data compiled from genetically engineered cell lines within an Alzheimer’s disease model showing that, at varying concentrations of IGC-AD1, the expression of GSK3β is reduced by as much as 62 percent. “Based on this and other previously announced compelling data, we are readying IGC-AD1, brand name Hyalolex, in a liquid formulation for commercialization in early 2018,” Ram Mukunda, CEO of IGC, stated in the news release. “We have identified Germany, Canada and certain licensed medical…

TuesdayOct 17, 2017 12:11 pm

CannabisNewsBreaks – PotNetwork Holding, Inc. (POTN) Subsidiary on Pace for Record-Breaking Quarter

PotNetwork Holding, Inc. (OTC: POTN) today announced that its wholly owned subsidiary, Diamond CBD, Inc., achieved combined sales of more than $3.2 million for July and August. This total is equivalent to 60 percent of the company’s revenues for the first six months of the year, leading PotNetwork to forecast another record-breaking quarter. This projection is further strengthened by Diamond CBD’s early reports for September sales, which the company notes “exceeded expectations” in spite of service interruptions stemming from Hurricane Irma. “We continue to be excited by our continued escalating revenues month-after-month,” Maria Gomez, regional vice president of sales for…

TuesdayOct 17, 2017 10:29 am

CannabisNewsBreaks – SinglePoint, Inc. (SING) Announces Acquisition of Profitable Denver-Based Company

Specialized holding company SinglePoint, Inc. (OTC: SING) this morning announced its acquisition of a 51 percent stake in JAG, a Denver-based group. Through July 2017, the newly-acquired JAG recorded $600,000 in revenue with gross margins of roughly 26 percent. These results followed full-year 2016 revenue of $700,000 and continued to build on the company’s trend of consistently achieving year-over-year growth since commencing operations in 2014. “We are very excited for this opportunity as it dramatically increases SinglePoint revenues and profitability,” Greg Lambrecht, CEO of SinglePoint, stated in the news release. “We look forward to continuing investing in and growing SinglePoint's…

TuesdayOct 17, 2017 10:02 am

CannabisNewsBreaks – InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Provides Update on INM-405 Development

Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced preclinical results in the development of INM-405 for the treatment of pain. Notably, results from the company’s studies suggest that peripheral application of certain cannabinoid compounds, alone or in combination, is effective in the treatment of craniofacial muscle pain disorders, without any observed CNS side effects. InMed suggests that this lack of side effects may position cannabinoid-based compounds as more desirable treatment options than existing systemic pain-relief administration. News of these findings follows the company’s recent filing of a provisional patent application in the United States…

TuesdayOct 17, 2017 9:32 am

CannabisNewsBreaks – ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Names Paul Lucas as New Board Chair

ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) this morning announced its appointment of Paul Lucas as its new independent chair following founder Ken Clement’s decision to step down from the position. Clement will continue to serve as a member of the company’s board of directors. “Ken’s visionary leadership has given ABcann a great foundation to build upon and we appreciate his years of dedicated service and contributions,” Paul Lucas stated in the news release. “Having him maintain his position on the Board will help the Company maintain continuity of leadership and historical knowledge. I am thrilled to take on the…

MondayOct 16, 2017 9:13 am

CannabisNewsBreaks – Global Payout, Inc. (GOHE) Subsidiary Makes Successful Showing at 2017 Southwest Cannabis Conference and Expo

Payment solutions company Global Payout, Inc. (OTC: GOHE) this morning announced that MoneyTrac Technology, Inc., its majority-owned subsidiary, in addition to its newly-acquired marketing and publishing entity, PotSaver, made a successful showing at last week’s Southwest Cannabis Conference and Expo in Phoenix, Arizona. “Attending this event was an excellent opportunity for us to share the vast array of technology and business-related solutions MoneyTrac has to offer to the many new and existing businesses in cannabis,” James Hancock, CEO of MoneyTrac, stated in the news release. “In having had the chance to speak with several different owners of these businesses, it…

FridayOct 13, 2017 11:34 am

CannabisNewsBreaks – International Endeavors Corp. (IDVV) Enters MOU with Kubby Cryogenics, Inc. to Expand Medical Cannabis Line

International Endeavors (OTC: IDVV) this morning said that it has signed a memorandum of understanding (MOU) with Kubby Cryogenics, Inc. Per the agreement, Kubby Cryogenics will seek to patent medical grade cannabis strains that are genetically profiled to treat specific diseases. The agreement also states that Steve Kubby will immediately become CEO of International Endeavors. Kubby Cryogenics has assembled a team of top scientists and geneticists to continue developing the company’s proprietary cryogenics products. "We will create a dispensary system for legal medical cannabis states standardizing the patient centered, consultation approach while presenting an enticing line of Adult Use products…

FridayOct 13, 2017 11:16 am

CannabisNewsBreaks – India Globalization Capital (NYSE: IGC) Achieves Breakthrough with Potential to Prevent, Combat Alzheimer’s

India Globalization Capital (NYSE MKT: IGC), a first mover in the cannabis-based combination therapy space, recently announced that it is readying a line of cannabis-based medical dispensary products that target Alzheimer’s disease (http://nnw.fm/l2NJw). IGC is engineering genetic cell lines which demonstrate that, at various concentrations of tetrahydrocannabinol (THC), the protein Aβ decreases as much as 40 percent without neuron damage. An article discussing this reads: “This compelling in vitro data, and the promise it shows as a preventative and powerful treatment against Alzheimer’s, makes IGC a company with valuation growth potential for investors. The commercial potential for an Alzheimer’s treatment…

News and publishing service for cannabis related companies

Contact us: 303.498.7722

CannabisNewsBreaks